A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/713 (2006.01) A61K 31/341 (2006.01) A61K 31/52 (2006.01) A61K 31/70 (2006.01) A61K 31/7072 (2006.01) A61K 31/7088 (2006.01) A61K 31/7105 (2006.01) A61K 45/06 (2006.01) A61P 31/18 (2006.01)
Patent
CA 2470204
In the treatment of HIV administration of dsRNA at an appropriate stage in highly active antiretroviral (HAART) therapy of HIV allows for the discontinuation of HAART by increasing the time to HIV rebound after stopping HAART.
Dans le traitement de l'infection par le VIH, l'administration d'ARN bicaténaire à un stade approprié, dans la thérapie antirétrovirale hautement active (HAART) du VIH, permet d'interrompre la thérapie HAART et d'augmenter ainsi le temps de rebond de la virémie VIH après l'arrêt de la thérapie HAART.
Carter William A.
Strayer David R.
Gowling Lafleur Henderson Llp
Hemispherx Biopharma
LandOfFree
Use of dsrnas in strategic therapeutic intervention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dsrnas in strategic therapeutic intervention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dsrnas in strategic therapeutic intervention of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1714042